NCT05195658 · ClinicalTrials.gov record · last posted 2022-02-28
Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)
StatusRecruiting
PhaseNot specified
Started2022-01-30
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 28, 2022 (before its estimated December 31, 2022 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Prospective, single-center, clinical registry of patients with acute stroke of carotid artery bifurcation origin undergoing endovascular treatment using the Micronet-covered CGUARD Stent to seal the culprit lesion under proximal cerebral protection (by transient flow reversal using balloon catheter such as the MoMa or FlowGate) with thrombus retrieval achieved through active aspiration ± stentriever use.
A study involving clinical and cerebrovascular imaging data evaluation in consecutive patients with acute stroke of carotid artery bifurcation origin, presenting in the time-window and/or cerebral tissue window allowing guideline-indicated reperfusion by interventional management.
A registry of consecutive patients with the study condition. An open-label study, without randomization - a single arm, single-center study in John Paul II Hospital in Krakow, Poland.
Amendment record
1 amendment on the ClinicalTrials.gov record
This ClinicalTrials.gov record has been amended once since 2022-01-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history.
See every version on ClinicalTrials.gov ↗
2022-02-23
Status change Not Yet Recruiting→Recruitingv1
| NCT Number |
NCT05195658 |
| Lead Sponsor |
John Paul II Hospital, Krakow
|
| Conditions |
Carotid Artery Stenosis, Acute Ischemic Stroke |
| Enrollment |
20 participants |
| Start Date |
2022-01-30 |
| Primary Completion |
2022-12-31 (estimated) |
| Study Completion |
2027-12-31 (estimated) |
| Updated on ClinicalTrials.gov |
2022-02-28 |